GSK plc GLAXF | OTC
$24.74
$0.00 | 0.00%
TREND SIGNAL:
|2026-10-20
|2026-10-20
Next Earnings: Oct 28, 2026
Company Overview:
Market Cap:
$99.13B
Trailing PE:
23.3x
FWD PE *:
13x
Payout Ratio (TTM):
62.2%
52-Week Range:
$20.97 - $31.48
* Forward PE is based on street estimates.
10 Year GLAXF Performance Metrics:
Total Return (with DRIP):
19.9% (1.84% CAGR)
Total Return (no DRIP):
14.6% (1.37% CAGR)
Share Price:
-1.0% (-0.10% CAGR)
Yield on Cost (with DRIP):
4.47%
Total Invested:
$10,000
Total Value (with DRIP):
$11,995
Total Return $ (with DRIP):
$1,995
Dividend Increase:
29.5% (2.68% CAGR)
Dividend Yield (FWD):
3.73% ($0.92)
GLAXF 10-yr Total Return ($10K invested)
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
GLAXF Share Price
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
All
GLAXF Price CAGR:1Y: 14.01%2Y: 14.17%5Y: 5.28%10Y: -0.22%
GLAXF Dividend Charts
GLAXF Dividend CAGR:1Y: 2.68%2Y: 8.11%5Y: 2.68%10Y: -0.32%
GLAXF Dividend Payout Ratio CAGR:1Y: 417.58%2Y: 0.00%5Y: 19.18%10Y: 3.88%
GLAXF Dividend to FCF Ratio CAGR:1Y: 0.00%2Y: -15.79%5Y: -14.97%10Y: -7.56%
Unlock All Reports & Research Dividend Stocks like a BOSS!
Get 3 Months Free with Annual Plan
Get 3 Months Free with Annual Plan
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
40% Lifetime Discount
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
40% Lifetime Discount
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
40% Lifetime Discount
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
Combined 55% Lifetime Discount
GLAXF Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:
GLAXF Revenue CAGR:1Y: 0.00%2Y: 2.45%5Y: -1.52%10Y: 1.09%
GLAXF EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: -19.18%10Y: -7.15%
🔓 See the full chart40% off right now · 7-day free trial
GLAXF Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: -20.48%10Y: -6.00%
🔓 See the full chart40% off right now · 7-day free trial
GLAXF EBITDA CAGR:1Y: 0.00%2Y: 49.07%5Y: -2.37%10Y: 4.70%
🔓 See the full chart40% off right now · 7-day free trial
GLAXF Free Cash Flow CAGR:1Y: 0.00%2Y: 28.97%5Y: 11.29%10Y: 5.55%
🔓 See the full chart40% off right now · 7-day free trial
GLAXF Free Cash Flow / Share CAGR:1Y: 64.48%2Y: 30.49%5Y: 11.41%10Y: 5.30%
🔓 See the full chart40% off right now · 7-day free trial
GLAXF Operating Income CAGR:1Y: 0.00%2Y: 59.53%5Y: -24.32%10Y: -10.33%
🔓 See the full chart40% off right now · 7-day free trial
GLAXF Gross Profit CAGR:1Y: 0.00%2Y: 6.23%5Y: 0.48%10Y: 2.36%
🔓 See the full chart40% off right now · 7-day free trial
GLAXF Shares Outstanding CAGR:1Y: 0.00%2Y: -0.22%5Y: 0.04%10Y: 0.35%
🔓 See the full chart40% off right now · 7-day free trial
GLAXF Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 38.24%
🔓 See the full chart40% off right now · 7-day free trial
GLAXF Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
GLAXF Expenses CAGR:1Y: 0.00%2Y: -37.81%5Y: -24.00%10Y: -4.10%
🔓 See the full chart40% off right now · 7-day free trial
🔓 See the full chart40% off right now · 7-day free trial
🔓 See the full chart40% off right now · 7-day free trial
🔓 See the full chart40% off right now · 7-day free trial
🔓 See the full chart40% off right now · 7-day free trial
🔓 See the full chart40% off right now · 7-day free trial
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
🔓 See the full chart40% off right now · 7-day free trial
GLAXF Actual Revenue CAGR:1Y: 0.00%2Y: 2.45%5Y: -1.52%10Y: 1.09%
🔓 See the full chart40% off right now · 7-day free trial
GLAXF Actual EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: -19.18%10Y: -7.15%
🔓 See the full chart40% off right now · 7-day free trial
GLAXF Actual Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: -20.48%10Y: -6.00%
🔓 See the full chart40% off right now · 7-day free trial
GLAXF Actual EBITDA CAGR:1Y: 0.00%2Y: 49.07%5Y: -2.37%10Y: 4.70%
Ratios, Profit Margins & Return on Capital:
🔓 See the full chart40% off right now · 7-day free trial
GLAXF Net Profit Margin CAGR:1Y: -78.05%2Y: 0.00%5Y: -19.26%10Y: -7.02%
🔓 See the full chart40% off right now · 7-day free trial
GLAXF Gross Profit Margin CAGR:1Y: 2.00%2Y: 3.49%5Y: 1.94%10Y: 1.21%
🔓 See the full chart40% off right now · 7-day free trial
GLAXF Price to Earnings CAGR:1Y: 471.90%2Y: 0.00%5Y: 34.11%10Y: 8.46%
🔓 See the full chart40% off right now · 7-day free trial
GLAXF Price To Sales Ratio CAGR:1Y: 27.25%2Y: 10.66%5Y: 8.61%10Y: 1.00%
🔓 See the full chart40% off right now · 7-day free trial
GLAXF Return on Capital Employed CAGR:1Y: -7.98%2Y: 239.81%5Y: 11.61%10Y: 5.41%
🔓 See the full chart40% off right now · 7-day free trial
GLAXF Return on Invested Capital CAGR:1Y: -4.75%2Y: 232.62%5Y: 16.79%10Y: 9.23%
GLAXF Dividends Info:
Annual Dividend:
$0.9216
Forward Yield:
3.73%
Ex-Dividend Date:
2026-08-14
Lifetime Dividends / Share:
$12.23
GLAXF Dividend History: Dates, Payments & Yield list
Below is a schedule of all GLAXF dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield
| Ex-Date | Payment Date | Amount | Yield | Forward Yield | Price on Ex-Date |
|---|---|---|---|---|---|
| 08/14/2026 | 10/08/2026 | $0.230 | 3.63% | 3.76% | $24.53 |
| 08/13/2026 | 08/17/2026 | $0.229 | 1.8% | 1.81% | $25.35 |
| 05/15/2026 | 07/09/2026 | $0.227 | 3.53% | 3.45% | $26.29 |
| 05/14/2026 | 07/09/2026 | $0.230 | 3.58% | 0% | $0.00 |
| 02/20/2026 | 04/09/2026 | $0.243 | 3.12% | 3.47% | $28.03 |
| 02/19/2026 | 02/23/2026 | $0.243 | 1.54% | 1.65% | $29.40 |
| 11/14/2025 | 01/08/2026 | $0.210 | 3.66% | 3.32% | $25.35 |
| 11/13/2025 | 01/08/2026 | $0.210 | 3.84% | 0% | $0.00 |
| 08/15/2025 | 10/09/2025 | $0.217 | 4.51% | 3.99% | $21.74 |
| 08/14/2025 | 08/18/2025 | $0.217 | 2.25% | 2.25% | $19.25 |
| 05/16/2025 | 07/10/2025 | $0.212 | 4.45% | 4.27% | $19.85 |
| 05/15/2025 | 05/19/2025 | $0.212 | 2.23% | 2.18% | $19.46 |
| 02/21/2025 | 04/10/2025 | $0.201 | 4.41% | 4.93% | $16.30 |
| 02/20/2025 | 02/24/2025 | $0.201 | 2.27% | 2.21% | $18.22 |
| 11/15/2024 | 01/09/2025 | $0.191 | 4.49% | 0% | $0.00 |
| 11/14/2024 | 11/18/2024 | $0.191 | 2.18% | 2.27% | $16.86 |
| 08/16/2024 | 10/10/2024 | $0.192 | 3.7% | 3.91% | $19.65 |
| 08/15/2024 | 08/19/2024 | $0.192 | 1.93% | 1.85% | $20.73 |
| 05/16/2024 | 07/11/2024 | $0.190 | 3.42% | 3.89% | $19.56 |
| 02/22/2024 | 04/11/2024 | $0.202 | 3.76% | 3.94% | $20.51 |
| 11/16/2023 | 01/11/2024 | $0.174 | 4.06% | 3.49% | $19.98 |
| 08/17/2023 | 10/12/2023 | $0.178 | 4.14% | 3.9% | $18.32 |
| 05/18/2023 | 07/13/2023 | $0.175 | 3.89% | 3.97% | $17.65 |
| 02/23/2023 | 04/13/2023 | $0.166 | 3.82% | 3.56% | $18.65 |
| 11/03/2016 | 11/10/2016 | $0.234 | 3.92% | 3.92% | $23.90 |
| 08/11/2016 | 08/18/2016 | $0.247 | 3.65% | 3.65% | $27.09 |
| 05/12/2016 | 05/19/2016 | $0.275 | 4.23% | 4.23% | $25.99 |
| 02/18/2016 | 02/25/2016 | $0.683 | 10.95% | 10.95% | $24.94 |
| 11/12/2015 | 11/19/2015 | $0.321 | 4.95% | 4.95% | $25.94 |
| 08/13/2015 | 08/20/2015 | $0.330 | 5.87% | 5.87% | $22.50 |
| 05/14/2015 | 05/21/2015 | $0.332 | 4.75% | 4.75% | $27.94 |
| 02/19/2015 | 02/26/2015 | $0.394 | 5.4% | 5.4% | $29.19 |
| 11/06/2014 | 11/13/2014 | $0.337 | 4.83% | 4.83% | $27.93 |
| 08/06/2014 | 08/13/2014 | $0.356 | 4.83% | 4.83% | $29.48 |
| 05/14/2014 | 05/21/2014 | $0.355 | 4.1% | 4.1% | $34.64 |
| 02/19/2014 | 02/26/2014 | $0.426 | 4.89% | 4.89% | $34.88 |
| 11/13/2013 | 11/20/2013 | $0.211 | 2.6% | 2.6% | $32.44 |
| 08/07/2013 | 08/14/2013 | $0.200 | 3.09% | 3.09% | $25.90 |
| 05/08/2013 | 05/15/2013 | $0.200 | 3.16% | 3.16% | $25.32 |
| 02/20/2013 | 02/27/2013 | $0.244 | 3.43% | 3.43% | $28.50 |
| 11/14/2012 | 11/21/2012 | $0.180 | 2.76% | 2.76% | $26.13 |
| 08/08/2012 | 08/15/2012 | $0.170 | 2.32% | 2.32% | $29.29 |
| 05/09/2012 | 05/16/2012 | $0.170 | 2.96% | 2.96% | $23.01 |
| 02/15/2012 | 02/22/2012 | $0.233 | 4.16% | 4.16% | $22.41 |
| 11/02/2011 | 11/09/2011 | $0.189 | 3.48% | 3.48% | $21.74 |
| 08/03/2011 | 08/10/2011 | $0.178 | 2.65% | 2.65% | $26.81 |
| 05/04/2011 | 05/11/2011 | $0.178 | 2.65% | 2.65% | $26.79 |
| 02/09/2011 | 02/16/2011 | $0.211 | 4.36% | 4.36% | $19.35 |
| 10/27/2010 | 11/03/2010 | $0.160 | 2.62% | 2.62% | $24.46 |
| 07/28/2010 | 08/04/2010 | $0.150 | 2.74% | 2.74% | $21.88 |
| 05/05/2010 | 05/12/2010 | $0.150 | 2.65% | 2.65% | $22.66 |
| 02/10/2010 | 02/17/2010 | $0.180 | 3.03% | 3.03% | $23.76 |
Projected Future Returns & Dividends for GLAXF
Based on past 10-year performance, here are GLAXF growth metrics:
Share price CAGR of -0.22%
Dividend CAGR of +2.68%
Using GLAXF CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| GLAXF (DRIP) | GLAXF - No DRIP | |
|---|---|---|
| Current Price | $24.74 | $24.74 |
| Start Shares | 404.20 | 404.20 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 617.02 | 404.20 |
| Dividends Payment | $0.30 | $0.30 |
| Annual Dividends | $741 | $485 |
| Yield on cost | 7.41% | 4.85% |
| Share Price | $24.19 | $24.19 |
| Total Dividends | $5,206 | $4,208 |
| Final Value | $14,927 | $13,986 |
Estimated Future Value + Dividends - GLAXF
NOTE: Above numbers are our estimate based on GLAXF's Dividend and Price CAGR over past 10 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Get the best Dividend Stock Research Tools:
Get 3 Months Free with Annual Plan
Get 3 Months Free with Annual Plan
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
40% Lifetime Discount
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
40% Lifetime Discount
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
40% Lifetime Discount
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
Combined 55% Lifetime Discount
Company Info
GSK plc (GLAXF) had its IPO on 2010-01-05, and is traded on OTC stock exchange.
GSK plc, a global healthcare and pharmaceutical leader with roots tracing back to 1715, is headquartered in Brentford, United Kingdom. Operating extensively across the UK, United States, and other international markets, its activities span the entire lifecycle of healthcare products, encompassing research, development, manufacturing, and commercialization. Its broad portfolio includes pharmaceuticals, vaccines, over-the-counter medications, and a range of health-focused consumer products. The company operates through four primary divisions: Pharmaceuticals, Pharmaceutical Research & Development, Vaccines, and Consumer Healthcare. Within its pharmaceutical arm, GSK provides therapeutic solutions for a broad spectrum of conditions. These include ailments in respiratory health, HIV, immuno-inflammation, oncology, viral infections, central nervous system disorders, cardiovascular and urogenital issues, metabolic diseases, bacterial infections, and dermatology. The consumer healthcare division delivers products across wellness, oral health, nutrition, and skin health categories. These are available in numerous formats, including nasal sprays, tablets, syrups, lozenges, gum and transdermal patches, caplets, infant syrup drops, liquid suspensions, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams, non-medicated patches, lip balms, gummies, and soft chews. GSK also maintains collaborative agreements with various organizations such as 23andMe, Lyell Immunopharma, Inc., Novartis, Sanofi SA, Surface Oncology, Progentec Diagnostics, Inc., Alector, Inc., and CureVac AG. Furthermore, strategic partnerships are in place with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The firm, known as GlaxoSmithKline plc until its name change to GSK plc in May 2022, embodies centuries of innovation in healthcare.
GLAXF website: https://www.gsk.com
Get Full Access to All Reports with DRIPCalc PRO
Get 3 Months Free with Annual Plan
Get 3 Months Free with Annual Plan
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
40% Lifetime Discount
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
40% Lifetime Discount
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
40% Lifetime Discount
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
Combined 55% Lifetime Discount
Loading signals…
DCF Model — GLAXF
Value from:
🔒 Upgrade to unlock
The full DCF valuation — fair value, implied growth and the price path — is a paid feature.
Upgrade
Pay up to today
—
vs current price $24.74
—
Cash flow & implied price by year
FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.
EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.
Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
| Year | FCF | Implied price |
|---|
Sensitivity — fair value: growth ↓ × target return →
